Trial Profile
A Parallel-Group, Placebo-Controlled Trial of AndroGel in Men With Major Depressive Disorder Who Display an Incomplete Response to Standard Antidepressant Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 16 Nov 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 16 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Mar 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.